============================================================
CASE STUDY VALIDATION SUMMARY
============================================================

Model Scenario: BASELINE
Case Studies Validated: 6

Results Overview:
------------------------------------------------------------
Case Study                Status          Score      Error     
------------------------------------------------------------
AlphaFold 2/3             rejected        0.00      1.68
GNoME                     rejected        0.00      2.56
ESM-3                     partial         0.54      0.46
Recursion Pharmaceuticals validated       0.97      0.03
Isomorphic Labs / AlphaFold 3 validated       0.94      0.06
Cradle Bio                validated       0.82      0.18
------------------------------------------------------------

Mean Score: 0.55
Mean Log Error: 0.83

Validation Status Distribution:
  rejected: 2
  partial: 1
  validated: 3

Key Insights:
----------------------------------------
Model Strengths (across case studies):
  + Model handles capability extensions (Type III shifts)
  + Correctly predicted physical bottleneck
  + Good fit for physical stages
  + Good fit for cognitive stages
  + Overall acceleration prediction within 2x of observed

Model Weaknesses (across case studies):
  - Model under-predicted acceleration (1.0x vs 365.0x)
  - Poor fit for physical stages
  - Model under-predicted acceleration (0.5x vs 24.3x)
  - Poor fit for cognitive stages
  - Model under-predicted acceleration (1.4x vs 4.0x)